Latest filing published 15 Oct 2026 for ANI Pharmaceuticals INC, €338k.
Insider track record
Nikhil Lalwani: trading record in brief
Nikhil Lalwani is a declared insider of ANI Pharmaceuticals Inc, with filings sourced from SEC (Form 4). In total, 3 filings cover trades dated from 25 August 2026 to 15 October 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 15 October 2026, reports a transaction of €338k in ANI Pharmaceuticals Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Nikhil Lalwani
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,400 shares@ US$70.16CommonSEC144:0001950047-26-010256
- 5,400 shares@ US$70.400.022% mcap100.0% of flowCommonSEC144:0001950047-26-009487
- 5,400 shares@ US$74.170.023% mcap100.0% of flowCommonSEC144:0001950047-26-008689
3 of 3 declarations
